CAS: 2183470-09-7
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | GCN2-IN-6 REF: 54-BUP14401CAS: 2183470-09-7 | ≥95% | 1.750,00 €~4.314,00 € | Mar 29 Abr 25 |
 | GCN2-IN-6 REF: 3D-IMD47009CAS: 2183470-09-7 | Min. 95% | A consultar | Mar 10 Jun 25 |
 | GCN2-IN-6 REF: TM-T11374CAS: 2183470-09-7 | 95.04% - 97.97% | 115,00 €~2.172,00 € | Lun 30 Jun 25 |
Ref: 54-BUP14401
| 50mg | 1.750,00 € | ||
| 500mg | 4.314,00 € |
Entrega estimada en Estados Unidos, el Martes 29 de Abril de 2025
GCN2-IN-6
CAS:2183470-09-7
Please enquire for more information about GCN2-IN-6 including the price, delivery time and more detailed …
Fórmula:
C19H12Cl2F2N4O3S
Pureza:
Min. 95%
Peso molecular:
485.3 g/mol
Ref: 3D-IMD47009
| 10mg | 868,00 € | ||
| 25mg | 1.334,00 € | ||
| 50mg | 2.078,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Junio de 2025
GCN2-IN-6
CAS:2183470-09-7
GCN2-IN-6: Potent, oral GCN2/PERK inhibitor; IC50s - GCN2: 1.8 nM (enzymatic), 9.3 nM (cellular); PERK: …
Fórmula:
C19H12Cl2F2N4O3S
Pureza:
95.04% - 97.97%
Forma y color:
Solid
Peso molecular:
485.29
Ref: TM-T11374
| 1mg | 115,00 € | ||
| 5mg | 274,00 € | ||
| 50mg | 1.293,00 € | ||
| 1mL*10mM (DMSO) | 303,00 € |
Entrega estimada en Estados Unidos, el Lunes 30 de Junio de 2025
